Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
3.020
-0.070 (-2.27%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kazia Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1.66 | 1.66 | 5.24 | 7.36 | 27.59 | 8.76 | Upgrade
|
| Cash & Short-Term Investments | 1.66 | 1.66 | 5.24 | 7.36 | 27.59 | 8.76 | Upgrade
|
| Cash Growth | -68.38% | -68.38% | -28.80% | -73.32% | 214.77% | 61.28% | Upgrade
|
| Accounts Receivable | - | - | 0 | - | - | 0 | Upgrade
|
| Other Receivables | 0.13 | 0.13 | 0.1 | 0.05 | 0.08 | 1.19 | Upgrade
|
| Receivables | 0.13 | 0.13 | 0.11 | 0.05 | 0.08 | 1.19 | Upgrade
|
| Prepaid Expenses | 0.59 | 0.59 | 1.63 | 2 | 1.72 | 0.54 | Upgrade
|
| Other Current Assets | 3.76 | 3.76 | 3.79 | 0.04 | 0.01 | 0.16 | Upgrade
|
| Total Current Assets | 6.15 | 6.15 | 10.77 | 9.45 | 29.39 | 10.65 | Upgrade
|
| Other Intangible Assets | 15.4 | 15.4 | 17.27 | 19.14 | 22 | 12.41 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 7.3 | 6.69 | - | Upgrade
|
| Total Assets | 21.59 | 21.59 | 28.08 | 35.89 | 58.09 | 23.06 | Upgrade
|
| Accounts Payable | 4.55 | 4.55 | 0.86 | 1.52 | 1.89 | 1.69 | Upgrade
|
| Accrued Expenses | 10.88 | 10.88 | 4.16 | 2.6 | 3.27 | 1.99 | Upgrade
|
| Short-Term Debt | 0.63 | 0.63 | 1.8 | 1.84 | - | - | Upgrade
|
| Other Current Liabilities | 9.73 | 9.73 | 0.75 | 0.76 | 3.16 | 1.39 | Upgrade
|
| Total Current Liabilities | 25.8 | 25.8 | 7.57 | 6.73 | 8.33 | 5.07 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.02 | 2.02 | 2.29 | 2.56 | 2.93 | 3.41 | Upgrade
|
| Other Long-Term Liabilities | 3.75 | 3.75 | 6.12 | 8.21 | 8.93 | 0.46 | Upgrade
|
| Total Liabilities | 31.6 | 31.6 | 16.03 | 17.61 | 20.24 | 8.94 | Upgrade
|
| Common Stock | 101.64 | 101.64 | 97.45 | 84.48 | 80.29 | 48.78 | Upgrade
|
| Retained Earnings | -115.13 | -115.13 | -89.08 | -68.62 | -44.2 | -36.19 | Upgrade
|
| Comprehensive Income & Other | 3.48 | 3.48 | 3.68 | 2.41 | 1.76 | 1.53 | Upgrade
|
| Total Common Equity | -10.02 | -10.02 | 12.05 | 18.27 | 37.85 | 14.13 | Upgrade
|
| Shareholders' Equity | -10.02 | -10.02 | 12.05 | 18.27 | 37.85 | 14.13 | Upgrade
|
| Total Liabilities & Equity | 21.59 | 21.59 | 28.08 | 35.89 | 58.09 | 23.06 | Upgrade
|
| Total Debt | 0.63 | 0.63 | 1.8 | 1.84 | - | - | Upgrade
|
| Net Cash (Debt) | 1.02 | 1.02 | 3.45 | 5.52 | 27.59 | 8.76 | Upgrade
|
| Net Cash Growth | -70.30% | -70.30% | -37.59% | -79.99% | 214.77% | 61.28% | Upgrade
|
| Net Cash Per Share | 0.39 | 0.39 | 1.87 | 4.17 | 23.44 | 12.00 | Upgrade
|
| Filing Date Shares Outstanding | 4.35 | 4.35 | 2.36 | 1.5 | 1.32 | 0.95 | Upgrade
|
| Total Common Shares Outstanding | 3.33 | 3.33 | 2.28 | 1.39 | 1.32 | 0.95 | Upgrade
|
| Working Capital | -19.65 | -19.65 | 3.21 | 2.72 | 21.06 | 5.59 | Upgrade
|
| Book Value Per Share | -3.01 | -3.01 | 5.28 | 13.17 | 28.67 | 14.93 | Upgrade
|
| Tangible Book Value | -25.42 | -25.42 | -5.22 | -0.86 | 15.85 | 1.72 | Upgrade
|
| Tangible Book Value Per Share | -7.64 | -7.64 | -2.29 | -0.62 | 12.01 | 1.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.